Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide

ARYC

SUNNYVALE, CA / ACCESSWIRE / May 7, 2015 / The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (OTCQB: ARYC) and the United States Department of Agriculture (USDA), "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens," entitles Arrayit to an exclusive license to commercialize the technology.

Much of the food consumed in the United States, including 50% of the produce the US consumes during the winter months, is grown outside of the country. Arrayit and the USDA are expanding their food safety testing patent filings worldwide to include key food producing nations including Brazil, Canada, China, the European Union, Mexico and Peru.

Arrayit and the USDA Agricultural Research Service (ARS) have developed a rapid, portable, cost-effective and high-throughput detection system for the surveillance of multiple bacterial and viral foodborne pathogens including Campylobacter, E. coli, hepatitis, Listeria, norovirus and Salmonella. Expanding the USDA's patent protection will allow commercial licensing opportunities for Arrayit in jurisdictions worldwide.

About Arrayit

Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Please visit www.arrayit.com for more information.

Safe Harbor Statement

We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2014.

CONTACT

Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com

SOURCE: Arrayit Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today